Principal Investigator
Terrence Bradley
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220733
Clinical Trial Summary
VenBom: A Phase 1 Study of Bomedemstat (IMG-7289), a Novel Inhibitor of Lysine-Specific Demethylase 1 (LSD1), in Combination with Venetoclax in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndromes (MDS).
Phase
Phase I
Funding Agency/Sponsor
Institutional
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647